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Introduction
Alpha-1 antitrypsin (AAT) deficiency and hereditary hemochromatosis (HH) are two of the most fatal genetic disorders in adult life, affecting million individuals worldwide. They are often under-
diagnosed conditions and diagnosis is only made when the patient is already in the advanced stages of disease. AAT deficiency results from mutations in one highly pleiomorphic gene located on the
long arm of chromosome 14, SERPINA 1, being Z and S mutations the most clinically relevant . These mutations, resulting from single nucleotide exchanges, create an abnormal folding of the AAT
protein, that will not be secreted, compromising the lungs protection from proteolytic attack by neutrophil elastase . Consequently, AAT deficit originates emphysema, chronic bronchitis, asthma or even
chronic obstructive pulmonary disease (COPD) and it is also strongly associated with various liver diseases [1]. On the other hand, HH disorder results from mutations in HFE gene, located in the short
arm of chromosome 6, that encodes a transmembrane protein involved in intestinal absorption of dietary iron. Particularly, C282Y and H63D mutations in HFE gene are reported to be the most
significantly associated with HH disorder resulting in increased iron absorption. This excessive iron progressively deposites in various tissues triggering cirrhosis, hepatic fibrosis, diabetes mellitus,
arthropathy or even hepatocarcinoma [2].
Objectives
Given the insufficient population-based information about the prevalence of these gene variants 
in the Portuguese population, the aims of this study were to:
• Determine the prevalence  of Z, S, C282Y and H63D mutations and their genotype combinations 
in a population sample from São Brás de Alportel, in the South of Portugal;
• Determine the association of these mutations with related chronic diseases.
Table 2 shows the calculated allelic frequencies, based on the genotype frequencies, and the
respective 95% CI. All the observed allelic frequencies were in Hardy-Weinberg Equilibrium.
Materials and Methods
• Sampling
Random sampling of participants was performed based on the National Health System card
number of the S. Brás de Alportel Health Centre users, that covers over 99% of the total
population. All participants were given a brief description of the objectives of the study, after
which they signed a consent form. Each participant has answered an exhaustive questionnaire
including health related questions and a sample of blood was collected.
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Figure1. A- Frequencies of the AAT associated genotypes; B- Frequencies of the HH associated genotypes (n=208; M 
represents non-S and non-Z alleles and wt represents Non-C282Y and non-H63D alleles).
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Table2. Observed allele frequencies and confidence interval (CI) on São Brás de Alportel population (n=208; zero was
assumed since lower limit of CI was a negative value).
In general, our results corroborate previously published studies confirming a considerable
prevalence of the involved allelic mutations in the Portuguese population [3,4]. However we have
found a higher prevalence for both Z and C282Y alleles, strongly associated with AAT and HH
disorders. For the Z allele we found a similar value (2,2%) reported recently for Madeira Island
(2,5%) that are similar to several Northern European countries [5,6]. In relation to the C282Y allele,
its higher frequency (3,6%) is not consistent with the north–south decreasing gradient that has
been found in mainland Portugal [4]. However, we have to consider the large amplitude of
confidence intervals associated. Moreover, we found no association between the analysed gene
variants and their related chronic diseases, including chronic bronchitis, asthma, COPD, cirrhosis,
diabetes mellitus and arthropathy, as reported by the participants likely due to the small sample
available.
• DNA extraction and genotyping
Genomic DNA was isolated from whole blood containing EDTA using standard methods. The
selected SNPs (rs28929474, rs17580, rs1800562, rs1799945) were typed by polymerase chain
reaction (PCR) followed by restriction fragment length polymorphism (RFLP) analysis. All the
information about PCR conditions, primers sequences and restriction enzymes is presented in
Table 1.
Analysis
Allele and genotype frequencies were determined by gene counting and the respective
confidence intervals were calculated. Statistical analysis was performed using SPSS Software.
Hardy-Weinberg equilibrium was tested for the genotype distribution of all investigated SNPs.
Results
In this study, participated 208 adult subjects, including 118 females and 90 males, with ages
ranging from 26 to 91 years old (mean age: 58 years). Figure 1 shows genotype frequencies
found in the studied population (n=208). Regarding AAT deficiency, we found a relative frequency
of 4,3% MZ (95% CI: 0-17,6), 0,5% SS (95% CI: 0-14,0) and 15,4% MS (95% CI: 2,9-27,9)
genotypes (Figure 1A). About HH, we found a relative frequency of 1,4% C282Y/H63D (95% CI: 0-
14,9), 2,4% H63D/H63D (95% CI: 0-15,8), 5,8% C282Y/wt (95% CI: 0-19,0) and 23,6% H63D/wt
(11,7-35,4) genotypes (Figure 1B).
Gene SNP ID Allele Primers sequence (5´→3´) Annealling
temp. (ºC)
Product
size (bp)
Restriction
enzyme
SERPINA1 rs 28929474 Z F: ATAAGGCTGTGCTGACCATCGTC
R: TTGGGTGGGATTCACCACTTTTC
58 179 TaqI
rs 17580 S F: TGAGGGGAAACTACAGCACCTCG
R: AGGTGTGGCAGCTTCTTGGTCA
59 121 TaqI
HFE rs1800562 C282Y F: ACGTTGGATGTACCCCAGATCACAATGAGG
R: ACGTTGGATGTGGATAACCTTGGCTGTACC
65 117 RsaI
rs1799945 H63D F: ACGTTGGATGTCTACTGGAAACCCATGGAG
R: ACGTTGGATGTTGAAGCTTTGGGCTACGTG
65 114 Bcll
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AAT Deficiency HH disorder
Allele Frequency (%) CI 95% Allele Frequency (%) CI 95%
Z 2,2 0-11,7 C282Y 3,6 0-13
S 8,2 0-17,4 H63D 14,9 6-23,8
M 89,6 86,6-92,8 wt 81,5 77,4-85,6
Table1. Primer sequences and PCR reaction conditions for the used PCR-RFLP method.
Conclusions
Given the variability of the prevalence of these mutations among different populations , the data
presented here is a contribution to better understand SERPINA1 and HFE mutations distribution in
Portugal.
Moreover, this kind of studies is crucial to estimate the number of individuals at risk of developing
the associated diseases allowing to early diagnosis mechanisms to reach asymptomatic patients.
Future studies involving a larger sample size will be necessary to evaluate the penetrance of the
studied gene mutations and to assess gene-environment interactions that influence disease risk,
contributing to reduce the burden of these diseases which can have a great public health impact.
